Showing posts with label opioids. Show all posts
Showing posts with label opioids. Show all posts

Saturday, May 4, 2019

FDA adds Boxed Warning for risk of serious injuries due to complex sleep behaviors with insomnia medicines




In a safety communication, the US Food and Drug Administration (FDA) has added a Boxed Warning, its most prominent warning, to the prescribing information and the patient Medication Guides for some common prescription insomnia medicines.

Additionally, the FDA now also requires a Contraindication, its strongest warning, to avoid use in patients who have previously experienced an episode of complex sleep behavior.

This warning comes after reports of rare but serious injuries that have happened with common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while not fully awake. In some cases, these complex sleep behaviors have been fatal.

These sleep behaviors are more common with eszopiclone, zaleplon and zolpidem.

Serious injuries and death from complex sleep behaviors have occurred in patients with and without a history of such behaviors, even at the lowest recommended doses, and the behaviors can occur after just one dose.

These behaviors can occur after taking these medicines with or without alcohol or other central nervous system depressants that may be sedating such as tranquilizers, opioids and anti-anxiety medicines.

(Source: US FDA, April 30, 2019)

Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA



Thursday, April 18, 2019

Can benzodiazepines, opioids and muscle relaxants be combined in one patient?


The answer is No. This can be deadly. Never prescribe all three drugs to one patient. If a patient overdoses on opioids, the doctor who prescribed them can expect a review of records. Prescribing two of the three drugs is even more risky.

If the combination is truly medically necessary, then your rationale for prescribing them should be documented.

Never prescribe even one of these medications without performing and documenting a thorough assessment and diagnosing a condition that necessitates their prescription.

Always bear in mind that the patient may already be receiving an opioid from one provider or a benzodiazepine from another provider and/or a muscle relaxant from a third provider.

So, before prescribing any of these medications, tick off these questions from your checklist:

1.     Does my patient have a medical diagnosis that calls for this medication?
2.     Could the benefit be achieved with nonsteroidal drug, or through physical therapy or other nonpharmacologic treatment?
3.     Is there a risk of abuse in my patient?
4.     Have I done a urine drug screen?
5.     Do I have a written agreement with this patient about the goals of care and the conditions under which I will prescribe this medication?
6.     Am I prepared to follow-up and assess whether the medication is effective? Will I stop prescribing the medication and taper it off if the patient is not improving?
7.     Am I following opioid prescribing guidelines, and am I following them? 


Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA